Immunotherapy of HPV-associated head and neck cancer: critical parameters - HAL-SHS - Sciences de l'Homme et de la Société Accéder directement au contenu
Article Dans Une Revue OncoImmunology Année : 2013

Immunotherapy of HPV-associated head and neck cancer: critical parameters

Résumé

Various arguments support the development of a vaccine targeting human papillomavirus (HPV) for the treatment of HPV-associated head and neck cancer. However, the mucosal localization of this tumor, the HPV-driven downregulation of MHC Class I molecules and various other immunosuppressive mechanisms must be carefully considered to improve the clinical efficacy of such an immunotherapeutic strategy.

Domaines

Linguistique

Dates et versions

halshs-01457167 , version 1 (06-02-2017)

Identifiants

Citer

Mevyn Nizard, Federico Sandoval, Cécile Badoual, Hélène Péré, Magali Terme, et al.. Immunotherapy of HPV-associated head and neck cancer: critical parameters . OncoImmunology, 2013, 2 (6), pp.e24534. ⟨10.4161/onci.24534⟩. ⟨halshs-01457167⟩
116 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More